0001127602-22-002347.txt : 20220128
0001127602-22-002347.hdr.sgml : 20220128
20220128113408
ACCESSION NUMBER: 0001127602-22-002347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220126
FILED AS OF DATE: 20220128
DATE AS OF CHANGE: 20220128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bihl Anthony P III
CENTRAL INDEX KEY: 0001432665
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 22566348
MAIL ADDRESS:
STREET 1: 807 SMITH RIDGE ROAD
CITY: NEW CANAAN
STATE: CT
ZIP: 06840
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-01-26
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001432665
Bihl Anthony P III
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
Common Stock
2022-01-26
4
A
0
3012
0
A
15408
D
Stock Options (Right to Buy)
20.75
2022-01-26
4
A
0
5656
0
A
2032-01-26
Common Stock
5656
5656
D
These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.
These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.
/s/ F. Mark Reuter as Attorney-in-Fact for Anthony P. Bihl III
2022-01-28